Posts by Anthony Rosenzweig, MD
-
Medical Grand Rounds: Cardiac Manifestations of COVID-19
On May 14, 2020, the tenth lecture in the Medical Grand Rounds' COVID-19 series featured a panel of experts who are investigating the cardiac manifestations of coronavirus. The panel included Mass General's Anthony Rosenzweig, MD, chief of cardiology, Jason Wasfy, MD, cardiologist, and Judy Hung, MD, cardiologist.
-
Study Shows ActRII Signaling Contributes to Heart Failure and Aging
Researchers at Massachusetts General Hospital show that increased activin type II pathway receptor signaling contributes to heart failure and aging, and the findings may lead to new therapeutic targets in heart disease.
-
Collaboration in Cardiology
Anthony Rosenzweig, MD, chief of Cardiology and co-director of the Corrigan Minehan Heart Center, discusses the multidisciplinary approach to patient care and research at Massachusetts General Hospital.
-
What Is Your New Year's Resolution?
Massachusetts General Hospital cardiologists were asked what their 2019 New Year's resolution is regarding their research and care. In this video, they give a variety of answers.
-
#AHA18: Scientific Sessions in Summary
Mass General physicians answer the question: "What was the most interesting topic presented at this year's Scientific Sessions?"
-
#AHA18 on Twitter: New Cholesterol Guidelines, the PIONEER-HF Trial and More
Health care professionals at this year’s American Heart Association's Scientific Sessions discussed late-breaking research, innovative treatment approaches and brand new guidelines. The conversations carried over from the podium and conference halls onto Twitter.
-
Specific microRNAs Linked to Post-MI Remodeling
By studying a large cohort of patients who had cardiac MRI after myocardial infarction, scientists at Massachusetts General have demonstrated the association of microRNAs with specific features of left ventricular remodeling, suggesting it may someday be possible to pinpoint early biomarkers of heart failure.
-
Five Sessions to See at #AHA18
From machine learning to metabolic disease, the topics discussed and presented by Mass General clinicians and researchers at #2018 foster a dialogue that contributes to the transformation of cardiovascular care in the practice setting and the improvement of heart health for patients.
-
Exercise Increases the Generation of New Cardiomyocytes
Research in animal models finds that exercise increases the generation of new cardiomyocytes. Enhancing the regenerative capacity of cardiomyocytes may help maintain heart function over time.
Biography
Anthony Rosenzweig, MD, is the chief of cardiology at Massachusetts General Hospital and co-director of the Corrigan Minehan Heart Center.
Dr. Rosenzweig attended Harvard Medical School, and completed his medical residency and cardiology fellowship at Mass General. His clinical interests include noninvasive clinical cardiology, cardiovascular genetics and cardiovascular disease prevention.
Dr. Rosenzweig practiced cardiology at Mass General, where he studied causes of heart failure and served as the director of the Cardiovascular Gene Therapy Program. He joined Beth Israel Deaconess Medical Center in 2006 as the director of cardiovascular research and associate chief of the Cardiovascular Division where he led the recruitment of investigators in the cardiovascular research program.
Dr. Rosenzweig is a widely published expert on mechanisms of heart failure and the benefits of exercise, and presents internationally on his research. He is also a member of numerous medical societies and has served in leadership roles within these institutions. He has published more than 150 scientific papers and his research has been continuously funded for more than twenty years.
Dr. Rosenzweig has held various leadership roles, including American Coordinator for a Leducq Foundation Network of Research Excellence, comprising 11 laboratories in Europe and the United States. He was also an associate editor of the New England Journal of Medicine from 2003 to 2013 and has served on numerous editorial boards including Cell Metabolism and Circulation Research.
